Rich Stuart's most recent trade in Tenax Therapeutics Inc was a trade of 250,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 10.22 per share. | 08 Dec 2025 | 2,500 | 5,266 (0%) | 0% | 10.2 | 25,542 | Common Stock |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 10.10 per share. | 08 Dec 2025 | 2,500 | 5,000 (0%) | 0% | 10.1 | 25,251 | Common Stock |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 9.20 per share. | 02 Dec 2025 | 2,500 | 2,500 (0%) | 0% | 9.2 | 22,998 | Common Stock |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 9.08 per share. | 02 Dec 2025 | 1,500 | 2,766 (0%) | 0% | 9.1 | 13,618 | Common Stock |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 9.01 per share. | 02 Dec 2025 | 1,000 | 1,266 (0%) | 0% | 9.0 | 9,006 | Common Stock |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 625,000 | 625,000 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | Rich Stuart | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 119 | 119 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 1,909,585 (28%) | 28% | 0 | Common Stock | |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 0 (0%) | 28% | 0 | Common stock | |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 1,909,585 (28%) | 28% | 0 | Common stock | |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 2,333,932 (34%) | 28% | 0 | Common Stock |